Get started
bioAffinity Technologies Inc Warrant 2022- on bioAffinitybioAffinity Technologies Inc Warrant 2022- on bioAffinitybioAffinity Technologies Inc Warrant 2022- on bioAffinity

bioAffinity Technologies Inc Warrant 2022- on bioAffinity

No trades
See on Supercharts
OverviewFinancialsNewsDiscussionsSeasonals

BIAFW chart


Full chart

BIAFW upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.88 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−20.9784 USD
Net income (FY)
‪−9.04 M‬ USD
Revenue (FY)
‪9.36 M‬ USD
Shares float
‪969.69 K‬
Beta (1Y)
−5.03

About bioAffinity Technologies, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Maria Zannes
Website
bioaffinitytech.com
Headquarters
San Antonio
Founded
2014
ISIN
US09076W1172
FIGI
BBG018DZJPN8
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIAFW news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.